Innovation, Med Tech, Regulatory
October 12, 2017
Via: medicaldevice-network.comThe US Food and Drug Administration (FDA) has approved Respicardia’s transvenous implantable neurostimulation system, remede, for moderate to severe central sleep apnea (CSA) in adults. Remede is designed to activate the phrenic nerve and engage the diaphragm to restore natural […]
March 28, 2024
April 19, 2024